EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 23 October 2025

Europe's choice

Geopolitical shifts are reshaping life sciences. Europe can build on its strengths and lead or stand still and fall behind. What will it choose?

Learn more here.

Recently published

Obesity is among the most pressing public health challenges of this century and one that is posing a significant burden on Europe’s population and health systems.

It is estimated that by 2030 more than 30% of Europeans will live with obesity, with the direct and indirect costs for healthcare systems estimated to reach up to EUR 1,597 billion if no holistic action is taken.

Read the full report here.

Events

Trials@Home Closing Event 2025
31 October 2025 (Utrecht, Hybrid)

Join the conference on 31 October, dedicated to presenting the project’s recommendations on the conduct of DCTs, featuring... Read more

IHI Brokerage Event 2025
04 November 2025 (Brussels, Belgium)

If you’re interested in future IHI funding opportunities, the IHI Brokerage Event is the ideal place to network and... Read more

POLITICO Health Care Summit 2025
18 November 2025 (Brussels, Belgium)

Join us on 18 November during the POLITICO Health Care Summit for the Fireside Chat | Unleashing the Future of Life... Read more

Future-proofing Alzheimer’s care: scaling innovation for a healthier Europe
04 December 2025 (Online)

Explore how new therapies and scalable solutions can transform care pathways and strengthen health systems. Read more

What we are reading

INTERVIEW: EU must 'continue to uphold science', says head of drug agency
On 20 October 2025 (Euractiv)

The EU’s new pharmaceutical legislation is one of the most important opportunities ahead, says EMA head Emer Cooke.

Factsheet – 30 years of medicines in the EU
On 19 October 2025 (European Commission)

Thirty years ago, the European Union took a decisive step to strengthen public health, foster innovation, and enhance... Read more

An EU Commitment towards UNderstanding CANcer
On 18 October 2025 (UNCAN)

Implementation plans of two convergent European initiatives, the Horizon Europe Mission Cancer and the Europe’s Beating... Read more

Trials@Home final recommendations cover the conduct of decentralised clinical trials
On 16 October 2025 (Trials@Home)

The Trials@Home consortium, a public-private partnership funded by the Innovative Medicines Initiative, has spent... Read more

Irish pharma sector hails €30m medicines boost and R&D tax credit increase
On 09 October 2025 (Euractiv)

Ireland’s bumper health budget unlocks innovative medicines cash, aims to spur global competitiveness.

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu